ROCHE HOLDING AG

World Rank (Dec-25-2022)
32
Market Cap (Dec-25-2022)
261.41 Billion USD
World Rank (Jan-07-2022)
25
Market Cap (Jan-07-2022)
356.150 Billion USD
World Rank (Sep-01-2021)
21
Market Cap (Sep-01-2021)
350.650 Billion USD
World Rank (Jan-01-2021)
25
Market Cap (Jan-01-2021)
295.780 Billion USD
World Rank (Jan-2020)
23
Market Cap (Jan 1st 2020)
279.684 Billion USD
Annual Revenue in USD
66,757 Million USD
Annual Net Income in USD
14,808 Million USD
Annual Results for Year Ending
Dec-2021
Total Assets in USD
98,133 Million USD
Total Liabilities in USD
72,101 Million USD
Total Equity in USD
26,032 Million USD
Headquarters Region / City
Basel
Headquarters Country
Switzerland
Headquarters Sub Region
Western Europe
Headquarters Continent
Europe
Company Business
Healthcare
Pharmaceutical
Medical Equipment
Biotechnology
Healthcare Service
Stock Category
S&P EUROPE 350
Stock Exchange
Switzerland
Company Rank in Country in 2022
Company Rank in Switzerland in 2022 is 2
Rank in Country (Jan-2021)
Company Rank in Switzerland in 2021 is 2
Number of Employees
103,613
Employee Count as on Date
As on 2022
Chairman
Christoph Franz
CEO:
Severin Schwan
Founders
Fritz Hoffmann-La Roche
Billionaires related to Enterprise:
Andre Hoffmann
Andreas Oeri
Maja Oeri
Catherine Oeri
Jorg Duschmale
Sabine Duschmale Oeri
Vera Michalski Hoffmann
Lukas Duschmale
Maja Hoffmann
Yahoo @ Switzerland
Wikipedia
Company Website:
Roche - Healthcare and Pharmaceutical Company
Founded Year
1896
Business Sector:
Top Healthcare Companies in Europe
Top Technology Companies in Europe
Top Pharmaceutical Companies in Europe
About Company Business:

Roche Holding is a pioneer in Healthcare Company with headquarters in Basel, Switzerland. Roche is the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in Roche Company products pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies. They are specialized in Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascular and Metabolism, Opthamology and Respiratory branches Medicines.

Roche Holding annual revenues for year ending December 2021 was 62.80 Billion CHF.

Roche Holding annual operating profit for year ending December 2021 is 13.49 Billion CHF.

As on December 2021, Roche Holding has 100,920 employees, 29 research and development sites in Pharmaceuticals and Diagnostics worldwide, 23 manufacturing sites in Pharmaceuticals and Diagnostics worldwide.

63 million patients treated with medicines of Roche Holding.

 

Annual Results Summary:

Roche Holding AG - Annual Results - Revenue and Net Profit - in Billion CHF

Annual Results Revenue Operating Income Net Income EPS (CHF)
Dec-2021 62.80 18.15 13.93 16.20
Dec-2020 58.32 18.54 14.29 16.52
Dec-2019 61.46 17.55 13.49 15.62
Dec-2018 56.84 14.74 10.50 12.29
Dec-2017 53.29 13.00  8.63 10.12
Dec-2016 50.57   9.57 11.24
Dec-2015 48.10   8.80 10.42
Balance Sheet Summary

Roche Holding AG - Balance Sheet Summary - in Million CHF

Yearly - Ending Total Assets Total Liabilities Total Equity
Dec-2021 92.31 67.8 24.4
Dec-2020 87.88 50.0 37.8
Dec-2019 86.14 49.7 36.3
Quarterly Results Summary:

Roche Holding AG - Half Yearly Results - Revenue and Net Profit - in Billion CHF

Half Year Ending Revenue Net Profit EPS (CHF)
Dec-2021 32.08 6.12 7.14
Jun-2021 30.71 7.80 9.14
Dec-2020 29.04 6.22 7.27
Jun-2020 29.28 8.46 10.44
Dec-2019 31.00 4.88 5.70
Jun-2019 30.47 8.62 11.12
Dec-2018 28.74 3.19 3.73
Jun-2018 28.11 7.31 8.56
Dec-2017 26.96 3.16 3.70
Cash, cash equivalents ending balances
3,770 Million CHF as on June 2020

Share it on Social Media